Summit Global Investments’s Evolus EOLS Stock Holding History

Summit Global Investments’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-59,100	Closed	-$450K	–	562
2021 Q3	$450K	Buy	+59,100	New	+$611K	0.03%	326

Other funds holding EOLS

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Summit Global Investments's EOLS Position: Q4 2021 in Review

Summit Global Investments sold out of Evolus (EOLS) in Q4 2021, closing a stake of 59,100 shares — an estimated $450K sold.

Summit Global Investments first reported a position in EOLS in Q3 2021 and held it in 1 quarter. The position peaked at $450K in Q3 2021. 104 funds tracked by Wall St. Rank hold EOLS as of Q4 2021.

Summit Global Investments reported no remaining Evolus position as of Q4 2021 after selling out during the quarter.
Summit Global Investments sold 59,100 Evolus shares in Q4 2021, an estimated $450K.
Summit Global Investments first reported a position in Evolus in Q3 2021 and held it in 1 quarter.
Summit Global Investments's Evolus position peaked at $450K in Q3 2021.
104 funds tracked by Wall St. Rank held Evolus as of Q4 2021.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.